| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |